BioSpace News Archive

Business

CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy

CStone Pharmaceuticals and Numab Therapeutics AG announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a potential best-in-class monovalent, tri-specific antibody-based molecule targeting PD-L1, 4-1BB, and human serum albumin.

May 1, 2019
·
5 min read
Three Keys to Success as a Pharmaceutical Entrepreneur

Success in the over-the-counter pharmaceutical market can seem unattainable for independent drug inventors and entrepreneurs. Shelves are stocked with brands so dominant they define generics and competitors

May 1, 2019
·
11 min read
Business

Arthur D. Little Report Explores Impact of “Ultra-targeted” Healthcare

As pivotal changes in healthcare and drug development gain traction, new analysis from Arthur D. Little (ADL) highlights that all sectors of the industry must evolve their business and operating models in the coming decade.

May 1, 2019
·
1 min read
Policy

Statement - CMA applauds new plain packaging regulations for tobacco products: Let’s do the same for e-cigarettes and vaping products

Canada continues to lead the way when it comes to tobacco regulations.

May 1, 2019
·
1 min read
Deals

Veracyte Announces Proposed Public Offering of Common Stock - May 1, 2019

Veracyte, Inc. announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock.

May 1, 2019
·
2 min read
Business

Nanobiotix announces first quarter 2019 revenue

NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the “Company”), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announces its unaudited revenue for the first quarter of 2019.

May 1, 2019
·
4 min read
Business

Enzyre appoints Dirk Pollet as Chief Executive Officer

Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, announces today the appointment of Dirk Pollet as Chief Executive Officer.

May 1, 2019
·
3 min read
Genetown

CARB-X launches new Funding Rounds to support the development of antibiotics, vaccines, diagnostics and other life-saving products that target drug-resistant bacteria

CARB-X announced today its 2019 rounds of funding to support the development of antibiotics, vaccines, biotherapeutics, diagnostics and other life-saving products to address the rising threat of drug-resistant bacteria.

May 1, 2019
·
10 min read
Business

James Gartner Joins AssureCare® in a Key Executive Role

AssureCare, the leading provider of healthcare management software and solutions, announced the appointment of James Gartner as its Executive Vice President of Clinical Strategy.

May 1, 2019
·
2 min read
Sareum to Present at BioTrinity 2019 in London

Sareum Holdings plc (AIM:SAR), the specialist small molecule drug development business, announces that its CEO, Dr Tim Mitchell, will give a company presentation at BioTrinity 2019 in London, which takes place from 30 April – 1 May.

May 1, 2019
·
2 min read